Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Myo-inositol/D-chiro-inositol in PCOS
NCT06170463Phase 1Completed
- Sponsor
- Zagazig University
- Start
- Aug 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metformin, myo-inositol and bCalm in polycystic ovary syndrome (PCOS), sponsored by Zagazig University. Started Aug 2022; status: completed.
02
Drugs
metforminmyo-inositolbCalm
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06170463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06170463.